- Home
- MIRM vs TSI Comparison
MIRM vs TSI Comparison
Compare MIRM & TSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MIRM | TSI |
|---|---|---|
| Founded | 2018 | 1987 |
| Country | United States | United States |
| Employees | 372 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 221.7M |
| IPO Year | 2019 | 1995 |
Fundamental Metrics
Financial Performance| Metric | MIRM | TSI |
|---|---|---|
| Price | $93.16 | $4.53 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $115.33 | N/A |
| AVG Volume (30 Days) | ★ 866.8K | 249.6K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.46% |
| EPS Growth | ★ 74.59 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,138,000.00 | N/A |
| Revenue This Year | $26.22 | N/A |
| Revenue Next Year | $21.77 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $36.88 | $4.43 |
| 52 Week High | $109.28 | $5.06 |
Technical Indicators
Market Signals| Indicator | MIRM | TSI |
|---|---|---|
| Relative Strength Index (RSI) | 52.37 | 38.06 |
| Support Level | $85.35 | N/A |
| Resistance Level | $96.65 | $4.95 |
| Average True Range (ATR) | 4.13 | 0.08 |
| MACD | 0.62 | -0.01 |
| Stochastic Oscillator | 66.98 | 24.10 |
Price Performance
Historical ComparisonAbout MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
About TSI TCW Strategic Income Fund Inc.
Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment and others.